I think that last paragraph from PD deserves fleshing out. Why has PD not come across any promotion, etc fron Pfizer?
- is it because Pfizer is strictly restricting themselves to office visits with cardios and PD has been dealing with pcp?
- waiting for the provincial reimbursements to kick in order to get the best bang from the rep-cardio interaction?
- is Pfizer slow walking V in Canada on purpose, and if so what is the purpose?
Since many of us have taken a strong interest in the news that Pfizer was going to do promotion for HLS in Canada and extrapolated that to ideas that it may show an interest in Amarin, it would be nice to know what is actually happening.
Market Data 
Markets 
AI
